Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

3401-3410 of 4090 results

Catalogue Number:

PX-TA1679

Category:

G

Proteo Genix logo

Licaminlimab Biosimilar – Anti-TNFA mAb – Research Grade

Target: TNFA
Target Alias Name: Licaminlimab/IMMUNOGLOBULIN/ ANTI-(HUMAN TUMOR NECROSIS FACTOR .ALPHA.) (HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL ESBA1622 SCFV FRAGMENT)/TNFA/anti-TNFA
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: Lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1334

Category:

G

Proteo Genix logo

Lifastuzumab Biosimilar – Anti-SLC34A2 mAb – Research Grade

Target: SLC34A2
Target Alias Name: Lifastuzumab/DNIB0600A (conjugate)/MNIB2126A (non conjugate)/SLC34A2/anti-SLC34A2
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1296

Category:

G

Proteo Genix logo

Ligelizumab Biosimilar – Anti-IGHE mAb – Research Grade

Target: IGHE
Target Alias Name: Ligelizumab/CL-2C/IGHE/anti-IGHE
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1787

Category:

G

Proteo Genix logo

Ligufalimab Biosimilar – Anti-CD47 mAb – Research Grade

Target: CD47
Target Alias Name: Ligufalimab/AK 117/ AK-117/ AK117/CD47/anti-CD47
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1378

Category:

G

Proteo Genix logo

Lilotomab Biosimilar – Anti-CD37 mAb – Research Grade

Target: CD37
Target Alias Name: Lilotomab/HH1/CD37/anti-CD37
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA2071

Category:

G

Proteo Genix logo

Linavonkibart Biosimilar – Anti-TGFB1 mAb – Research Grade

Target: TGFB1
Target Alias Name: anti-TGFB1/ Transforming growth factor beta-1 proprotein/ LAP/ TGF-beta-1/ TGFB
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1046

Category:

G

Proteo Genix logo

Lintuzumab Biosimilar – Anti-CD33 mAb – Research Grade

Target: CD33
Target Alias Name: Lintuzumab/225Ac-lintuzumab/HuM195/SGN-33/SMART M195/CD33/anti-CD33
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1859

Category:

G

Proteo Genix logo

Linvoseltamab Biosimilar – Anti-TNFRSF17 mAb – Research Grade

Target: TNFRSF17
Target Alias Name: Linvoseltamab//TNFRSF17/anti-TNFRSF17
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4/G4 Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA2072

Category:

G

Proteo Genix logo

Lipustobart Biosimilar – Anti-PD1 mAb – Research Grade

Target: PD1
Target Alias Name: anti-PD1/ Programmed cell death protein 1/ Protein PD-1/ hPD-1/ PDCD1/ CD279
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1860

Category:

G

Proteo Genix logo

Lirentelimab Biosimilar – Anti-SIGLEC8 mAb – Research Grade

Target: SIGLEC8
Target Alias Name: Lirentelimab//SIGLEC8/anti-SIGLEC8
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1 Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo